Longevity Health Holdings, Inc. Common Stock
XAGE
XAGE was delisted on the 11th of September, 2025.
27 hedge funds and large institutions have $102M invested in Longevity Health Holdings, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
31% more capital invested
Capital invested by funds: $77.6M → $102M (+$24M)
4% more funds holding
Funds holding: 26 → 27 (+1)
0.5% more ownership
Funds ownership: 1.69% → 2.19% (+0.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$14.3M |
| 2 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
+$14.3M |
| 3 |
Millennium Management
New York
|
+$5.38M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$4.82M |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$144K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$14.4M |
| 2 |
EAM
Exos Asset Management
New York
|
-$875K |
| 3 |
CM
Crestline Management
Fort Worth,
Texas
|
-$725K |
| 4 |
CS
Clear Street
New York
|
-$89K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Verition Fund Management
Greenwich,
Connecticut
| $99K | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $12K | +$12.2K | +42 | New |
|
|
UOC
28
UBS O'Connor
Chicago,
Illinois
| – | -$14.4M | -49,500 | Closed |
|
|
CM
29
Crestline Management
Fort Worth,
Texas
| – | -$725K | -2,500 | Closed |
|
|
CS
30
Clear Street
New York
| – | -$89K | -309 | Closed |
|
XAGE Hedge Fund Activity: Q1 2022 in Review
27 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Common Stock (XAGE) for Q1 2022, worth a combined $102M — up 31% from $77.6M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new XAGE positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Linden Advisors, opening a new position worth an estimated $14.3M. The largest seller was UBS O'Connor, exiting entirely with an estimated $14.4M sold.
- 27 institutional investors held Longevity Health Holdings, Inc. Common Stock (XAGE) as of Q1 2022, up from 26 in Q4 2021.
- Funds reported $102M of Longevity Health Holdings, Inc. Common Stock stock for Q1 2022, up 31% quarter-over-quarter.
- 4 funds opened new Longevity Health Holdings, Inc. Common Stock positions in Q1 2022 and 3 closed out, a net change of +1 holder.
- The largest Longevity Health Holdings, Inc. Common Stock buyer in Q1 2022 was Linden Advisors, an estimated $14.3M added.
- The largest Longevity Health Holdings, Inc. Common Stock seller in Q1 2022 was UBS O'Connor, an estimated $14.4M sold.
Based on aggregated 13F filings for Q1 2022.